What's Happening?
The U.S. Environmental Protection Agency (EPA) announced on November 13, 2026, the availability of 24 studies related to its draft risk evaluation for 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[γ]-2-benzopyran (HHCB), also known as galaxolide.
These studies, considered under the Toxic Substances Control Act (TSCA), were previously inaccessible to the public due to an administrative issue in the EPA's Health and Environmental Research Online (HERO) database. HHCB is a synthetic musk widely used in fragrances and household products. The EPA resolved the issue on October 14, 2026, making the studies publicly available. To ensure public review, the EPA is opening a 30-day public comment period, limited to these newly available materials, with comments due by December 16, 2026.
Why It's Important?
This action by the EPA is significant for ensuring transparency and public participation in chemical risk assessments. The inaccessibility of these 24 studies had previously hindered the public's ability to fully review the scientific basis of the EPA's draft risk evaluation for HHCB. By making these studies available and opening a dedicated comment period, the EPA is upholding its commitment to a comprehensive and publicly informed review process. HHCB's widespread use in consumer products means that its risk evaluation has broad implications for public health and safety. This move allows stakeholders, including industry, environmental groups, and the general public, to scrutinize the data that informed the EPA's assessment, potentially leading to a more robust and credible final risk evaluation. It also reinforces the principle that regulatory decisions should be based on a full body of accessible scientific evidence.
What's Next?
Upon the publication of the Federal Register notice on November 16, 2026, a list of the 24 studies will be included in the HHCB Data Availability Memorandum in docket EPA-HQ-OPPT-2018-0430. The public will have until December 16, 2026, to submit comments specifically on these newly available materials. It is important to note that this comment period does not reopen the entire draft risk evaluation for HHCB. Following the close of the comment period, the EPA will review the submitted feedback as it finalizes its risk evaluation for HHCB. The outcome of this process could influence future regulatory actions concerning the use of HHCB in consumer products, potentially leading to restrictions or other risk management measures if deemed necessary based on the comprehensive scientific review.
Beyond the Headlines
The incident of inaccessible studies highlights the critical importance of robust data management and public access systems within regulatory agencies. Even administrative glitches can undermine public trust and the integrity of scientific review processes. The EPA's corrective action and subsequent comment period demonstrate a commitment to rectifying such issues and ensuring that regulatory decisions are transparent and well-supported by publicly available data. This event also underscores the ongoing challenges in managing the vast amount of scientific information required for chemical risk assessments under TSCA. The public's ability to access and comment on the same information used by the EPA is fundamental to democratic governance and effective environmental protection, fostering accountability and informed decision-making in the regulation of widely used chemical substances.
